Siegel, D. S., & Goldschmidt, H. (2016). Pomalidomide plus low-dose dexamethasone in patients with relapsed/refractory multiple myeloma and moderate renal impairment: A pooled analysis of three clinical trials. Leukemia and lymphoma, 57(12), . https://doi.org/10.1080/10428194.2016.1177181
Chicago-Zitierstil (17. Ausg.)Siegel, David S., und Hartmut Goldschmidt. "Pomalidomide Plus Low-dose Dexamethasone in Patients with Relapsed/refractory Multiple Myeloma and Moderate Renal Impairment: A Pooled Analysis of Three Clinical Trials." Leukemia and Lymphoma 57, no. 12 (2016). https://doi.org/10.1080/10428194.2016.1177181.
MLA-Zitierstil (9. Ausg.)Siegel, David S., und Hartmut Goldschmidt. "Pomalidomide Plus Low-dose Dexamethasone in Patients with Relapsed/refractory Multiple Myeloma and Moderate Renal Impairment: A Pooled Analysis of Three Clinical Trials." Leukemia and Lymphoma, vol. 57, no. 12, 2016, https://doi.org/10.1080/10428194.2016.1177181.